Lista de obras -

A Year in the Life of the EU-CardioRNA COST Action: CA17129 Catalysing Transcriptomics Research in Cardiovascular Disease

scientific article published on 18 May 2020

Absence of Thrombospondin-2 Causes Age-Related Dilated Cardiomyopathy

scientific article published on 05 October 2009

Absence of thrombospondin-2 increases cardiomyocyte damage and matrix disruption in doxorubicin-induced cardiomyopathy

scientific article published on 23 May 2011

AntagomiR-103 and -107 Treatment Affects Cardiac Function and Metabolism

artículo científico publicado en 2018

Biologically relevant effects of mRNA amplification on gene expression profiles

artículo científico publicado en 2006

CARMEN, a human super enhancer-associated long noncoding RNA controlling cardiac specification, differentiation and homeostasis.

artículo científico publicado en 2015

Cartilage intermediate layer protein 1 (CILP1): A novel mediator of cardiac extracellular matrix remodelling

artículo científico publicado en 2017

Circulating MicroRNA-208b and MicroRNA-499 reflect myocardial damage in cardiovascular disease.

artículo científico publicado en 2010

Dichotomy between the transcriptomic landscape of naturally versus accelerated aged murine hearts

artículo científico publicado en 2020

Functional Screening Identifies MicroRNAs as Multi-Cellular Regulators of Heart Failure

Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction

artículo científico publicado en 2004

Genome-wide profiling of the cardiac transcriptome after myocardial infarction identifies novel heart-specific long non-coding RNAs

artículo científico publicado en 2014

Hematopoietic miR155 deficiency enhances atherosclerosis and decreases plaque stability in hyperlipidemic mice.

artículo científico publicado en 2012

High-Sensitivity Troponin-T and Cardiovascular Outcomes in the Community: Differences Between Women and Men

scientific article published on 01 June 2020

Imatinib attenuates end-organ damage in hypertensive homozygous TGR(mRen2)27 rats

artículo científico publicado en 2006

Increased cardiac expression of tissue inhibitor of metalloproteinase-1 and tissue inhibitor of metalloproteinase-2 is related to cardiac fibrosis and dysfunction in the chronic pressure-overloaded human heart

artículo científico publicado en 2005

Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology

artículo científico publicado en 2009

Inflammation in viral myocarditis: friend or foe? ⬇️

artículo científico publicado el 20 de junio de 2012

Inhibition of MicroRNA-146a and Overexpression of Its Target Dihydrolipoyl Succinyltransferase Protect Against Pressure Overload-Induced Cardiac Hypertrophy and Dysfunction

artículo científico publicado en 2017

Integrated genomic approaches implicate osteoglycin (Ogn) in the regulation of left ventricular mass

artículo científico publicado en 2008

Long Non-Coding RNA Malat-1 Is Dispensable during Pressure Overload-Induced Cardiac Remodeling and Failure in Mice

artículo científico publicado en 2016

Long Noncoding RNA-Enriched Vesicles Secreted by Hypoxic Cardiomyocytes Drive Cardiac Fibrosis

artículo científico publicado en 2019

Long non-coding RNAs in the failing heart and vasculature.

artículo científico publicado en 2018

Long noncoding RNA MALAT1-derived mascRNA is involved in cardiovascular innate immunity.

artículo científico publicado en 2016

Long noncoding RNAs in cardiac development and ageing

artículo científico

Lysosomal integral membrane protein 2 is a novel component of the cardiac intercalated disc and vital for load-induced cardiac myocyte hypertrophy

artículo científico publicado en 2007

Macrophage microRNA-155 promotes cardiac hypertrophy and failure.

artículo científico publicado en 2013

MiRNA Deregulation in Cardiac Aging and Associated Disorders

artículo científico publicado en 2017

MicroRNA involvement in immune activation during heart failure

scientific article published on April 2011

MicroRNA profiling identifies microRNA-155 as an adverse mediator of cardiac injury and dysfunction during acute viral myocarditis

artículo científico publicado en 2012

MicroRNA-155 Amplifies Nitric Oxide/cGMP Signaling and Impairs Vascular Angiotensin II Reactivity in Septic Shock

artículo científico publicado en 2018

MicroRNA-221/222 Family Counteracts Myocardial Fibrosis in Pressure Overload-Induced Heart Failure.

artículo científico publicado en 2017

MicroRNAs and beyond: the heart reveals its treasures

artículo científico publicado en 2009

MicroRNA‐18 and microRNA‐19 regulate CTGF and TSP‐1 expression in age‐related heart failure ⬇️

artículo científico publicado el 25 de mayo de 2011

Missing links in cardiology: long non-coding RNAs enter the arena

artículo científico

Regulatory RNAs in Heart Failure

scientific article published on 27 January 2020

Reviewing the Limitations of Adult Mammalian Cardiac Regeneration: Noncoding RNAs as Regulators of Cardiomyogenesis

scientific article published on 10 February 2020

Sex-specific associations of obesity and N-terminal pro-B-type natriuretic peptide levels in the general population

artículo científico publicado en 2018

Small but smart--microRNAs in the centre of inflammatory processes during cardiovascular diseases, the metabolic syndrome, and ageing

artículo científico publicado en 2011

Targeted HFpEF therapy based on matchmaking of human and animal models

scientific article published on 21 September 2018

The long noncoding RNA Wisper controls cardiac fibrosis and remodeling

artículo científico publicado en 2017

The microRNA-15 family inhibits the TGFβ-pathway in the heart

artículo científico publicado en 2014

The microRNA-221/-222 cluster balances the antiviral and inflammatory response in viral myocarditis.

artículo científico publicado en 2015

Thrombospondin-2 Is Essential for Myocardial Matrix Integrity: Increased Expression Identifies Failure-Prone Cardiac Hypertrophy

artículo científico publicado en 2004

Transcriptome-wide co-expression analysis identifies LRRC2 as a novel mediator of mitochondrial and cardiac function.

artículo científico publicado en 2017

Use of circulating microRNAs to diagnose acute myocardial infarction

scientific article published on 17 January 2012

miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling

artículo científico publicado en 2009

microRNA-122down-regulation may play a role in severe myocardial fibrosis in human aortic stenosis through TGF-β1up-regulation

artículo científico publicado en 2014

tRNAs and tRNA fragments as modulators of cardiac and skeletal muscle function

scientific article published on 31 March 2019

Lista de obras de

A Year in the Life of the EU-CardioRNA COST Action: CA17129 Catalysing Transcriptomics Research in Cardiovascular Disease

Absence of Thrombospondin-2 Causes Age-Related Dilated Cardiomyopathy

Absence of thrombospondin-2 increases cardiomyocyte damage and matrix disruption in doxorubicin-induced cardiomyopathy

AntagomiR-103 and -107 Treatment Affects Cardiac Function and Metabolism

Biologically relevant effects of mRNA amplification on gene expression profiles

CARMEN, a human super enhancer-associated long noncoding RNA controlling cardiac specification, differentiation and homeostasis.

Cartilage intermediate layer protein 1 (CILP1): A novel mediator of cardiac extracellular matrix remodelling

Circulating MicroRNA-208b and MicroRNA-499 reflect myocardial damage in cardiovascular disease.

Dichotomy between the transcriptomic landscape of naturally versus accelerated aged murine hearts

Functional Screening Identifies MicroRNAs as Multi-Cellular Regulators of Heart Failure

Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction

Genome-wide profiling of the cardiac transcriptome after myocardial infarction identifies novel heart-specific long non-coding RNAs

Hematopoietic miR155 deficiency enhances atherosclerosis and decreases plaque stability in hyperlipidemic mice.

High-Sensitivity Troponin-T and Cardiovascular Outcomes in the Community: Differences Between Women and Men

Imatinib attenuates end-organ damage in hypertensive homozygous TGR(mRen2)27 rats

Increased cardiac expression of tissue inhibitor of metalloproteinase-1 and tissue inhibitor of metalloproteinase-2 is related to cardiac fibrosis and dysfunction in the chronic pressure-overloaded human heart

Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology

Inflammation in viral myocarditis: friend or foe? ⬇️

Inhibition of MicroRNA-146a and Overexpression of Its Target Dihydrolipoyl Succinyltransferase Protect Against Pressure Overload-Induced Cardiac Hypertrophy and Dysfunction

Integrated genomic approaches implicate osteoglycin (Ogn) in the regulation of left ventricular mass

Long Non-Coding RNA Malat-1 Is Dispensable during Pressure Overload-Induced Cardiac Remodeling and Failure in Mice

Long Noncoding RNA-Enriched Vesicles Secreted by Hypoxic Cardiomyocytes Drive Cardiac Fibrosis

Long non-coding RNAs in the failing heart and vasculature.

Long noncoding RNA MALAT1-derived mascRNA is involved in cardiovascular innate immunity.

Long noncoding RNAs in cardiac development and ageing

Lysosomal integral membrane protein 2 is a novel component of the cardiac intercalated disc and vital for load-induced cardiac myocyte hypertrophy

Macrophage microRNA-155 promotes cardiac hypertrophy and failure.

MiRNA Deregulation in Cardiac Aging and Associated Disorders

MicroRNA involvement in immune activation during heart failure

MicroRNA profiling identifies microRNA-155 as an adverse mediator of cardiac injury and dysfunction during acute viral myocarditis

MicroRNA-155 Amplifies Nitric Oxide/cGMP Signaling and Impairs Vascular Angiotensin II Reactivity in Septic Shock

MicroRNA-221/222 Family Counteracts Myocardial Fibrosis in Pressure Overload-Induced Heart Failure.

MicroRNAs and beyond: the heart reveals its treasures

MicroRNA‐18 and microRNA‐19 regulate CTGF and TSP‐1 expression in age‐related heart failure ⬇️

Missing links in cardiology: long non-coding RNAs enter the arena

Regulatory RNAs in Heart Failure

Reviewing the Limitations of Adult Mammalian Cardiac Regeneration: Noncoding RNAs as Regulators of Cardiomyogenesis

Sex-specific associations of obesity and N-terminal pro-B-type natriuretic peptide levels in the general population

Small but smart--microRNAs in the centre of inflammatory processes during cardiovascular diseases, the metabolic syndrome, and ageing

Targeted HFpEF therapy based on matchmaking of human and animal models

The long noncoding RNA Wisper controls cardiac fibrosis and remodeling

The microRNA-15 family inhibits the TGFβ-pathway in the heart

The microRNA-221/-222 cluster balances the antiviral and inflammatory response in viral myocarditis.

Thrombospondin-2 Is Essential for Myocardial Matrix Integrity: Increased Expression Identifies Failure-Prone Cardiac Hypertrophy

Transcriptome-wide co-expression analysis identifies LRRC2 as a novel mediator of mitochondrial and cardiac function.

Use of circulating microRNAs to diagnose acute myocardial infarction

miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling

microRNA-122down-regulation may play a role in severe myocardial fibrosis in human aortic stenosis through TGF-β1up-regulation

tRNAs and tRNA fragments as modulators of cardiac and skeletal muscle function